UBS Group’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13
Closed -$1.73K 10511
2024
Q2
$1.73K Buy
13
+11
+550% +$2.2K ﹤0.01% 8505
2024
Q1
$384 Buy
+2
New +$500 ﹤0.01% 8594
2023
Q4
Sell
-1
Closed -$1.51K 10347
2023
Q3
$1.51K Hold
1
﹤0.01% 7914
2023
Q2
$1.68K Buy
+1
New +$3.21K ﹤0.01% 7870
2023
Q1
Hold
0
-$5.36K 10944
2022
Q4
Hold
0
9190
2022
Q2
Hold
0
-$2K 11280
2022
Q1
Hold
0
9726

Other funds holding TCBP

UBS Group's TCBP Position: Q3 2024 in Review

UBS Group sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q3 2024, closing a stake of 13 shares — an estimated $1.73K sold.

UBS Group first reported a position in TCBP in Q2 2023 and held it in 4 quarters. The position peaked at $1.73K in Q2 2024. 7 funds tracked by Wall St. Rank hold TCBP as of Q3 2024.

  • UBS Group reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 13 TC BioPharm (Holdings) plc American Depositary Shares shares in Q3 2024, an estimated $1.73K.
  • UBS Group first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q2 2023 and held it in 4 quarters.
  • UBS Group's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $1.73K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.